Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Share-based compensation expense

Asset impairment and restructuring costs

Expected credit losses on financial assets and related charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Canopy Growth

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The firm operates through the following segments: Canada Cannabis, Rest-of-world Cannabis, Storz and Bickel, BioSteel, This Works, and Other. The Canada Cannabis segment includes the production, distribution, and sale of cannabis, hemp, and cannabis products in Canada. The Rest-of-world Cannabis segment focuses on production and sale of cannabis, hemp, and cannabis products internationally. The Storz and Bickel segment produces and sells vaporizers. The BioSteel segment refers to the sale of consumer packaged goods including sports nutrition beverages, hydration mixes, proteins, and other specialty nutrition products. The This Works segment includes the production and sale of beauty, skincare, wellness, and sleep products, some of which have been blended with hemp-derived CBD isolate. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

SelectQuote

Zillow

Despite the fact that financial markets are volatile because of the Covid-19 pandemic, investors can still benefit by making sound investment decisions.

Three Stocks To Consider Buying In May

Fisker Inc

Workhorse Group

There's a dispute about whether we are in a stock market bubble, but no one argues that many stocks have reached bubble territory. The post 3 Stock Market Bubble Stocks to Avoid appeared first on InvestorPlace.

3 Stock Market Bubble Stocks to Avoid

Vertically integrated cannabis company Acreage Holdings, Inc. (CSE:ACRG) (OTC:ACRGF) and Medterra CBD, LLC are joining forces to develop a CBD-based collection of products. The move follows the recent sale of Acreage's Florida operations to Red White & Bloom Brands, Inc. (CSE:RWB) (OTCQX:RWBYF) for $60 million.

Acreage Holdings Teams Up With Medterra To Develop CBD Collection

HEXO Corp

Tilray Brands

Canadian Cannabis Stocks For Your Portfolio In May The post Are These The Top Canadian Marijuana Stocks To Buy Next Week? appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Are These The Top Canadian Marijuana Stocks To Buy Next Week?

MedMen Enterprises Inc.

3 Ways To Invest In Cannabis The post 3 Different Ways To Invest In Marijuana Stocks Right Now appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

3 Different Ways To Invest In Marijuana Stocks Right Now

Marijuana stock Canopy Growth Corp. is coming down from its high. Here's how investors can profit with CGC stock options.

Canopy Growth Corp. Has Lost its Sizzle

On the surface, CGC stock benefits from strong consumer incentives, but the cannabis market is steadily becoming overcrowded. The post Canopy Growth Has a Commoditization Problem appeared first on InvestorPlace.

Canopy Growth Has a Commoditization Problem

Aphria

Today, cannabis stocks are taking off as enthusiasm appears to be building in this hyper-growth segment of the market once again. The post Cannabis Stocks: Why HEXO, TLRY, APHA, CGC Stocks Gained Today appeared first on InvestorPlace.

Cannabis Stocks: Why HEXO, TLRY, APHA, CGC Stocks Gained Today

Aurora Cannabis

Cronos Group

How to approach and invest in the cannabis industry the Foolish way.

Investing in Cannabis Stocks? Check Out This Podcast.

Shares of cannabis companies such as Tilray, Inc. (NASDAQ:TLRY) and Canopy Growth Corporation (NASDAQ:CGC) are trading higher after BofA Securities reinstated a Buy rating on the stocks. BofA Securities analyst Heather Balsky reinstated a Buy rating on Tilray's stock with a $23 price target, while Canopy Growth received a $36 price target.

Why Tilray And Canopy Growth Are Trading Higher Today

Valuation multiples for cannabis stocks are likely to expand over the next year as the U.S. government reaches milestones on the path to federal cannabis legalization, according to BofA Securities. The Cannabis Analyst: Heather Balsky reinstated coverage of four cannabis stocks in separate notes:

BofA On Cannabis Stocks: Bullish On Tilray, Canopy Growth, Bearish On Cronos

OrganiGram Holdings Inc.

Looking for cannabis exposure? These seven weed stocks based in Canada could provide some explosive growth to portfolios over time.

7 Marijuana Stocks to Buy As Canada's Consumption Continues to Rise

It would be fair to say that cannabis stocks received three positive indicators over the past six months.

BofA Analysts Say These Are the 2 Weed Stocks to Buy

As New York's recreational cannabis industry shapes up, a group of individuals will play a big role in shaping the market's future. The Empire State legalized cannabis on March 31. More regulations and details are expected in the coming months as members are appointed to the Office of Cannabis Management and Cannabis Control Board — the regulatory bodies responsible for the industry.

See the power players shaping the future of New York's $7 billion cannabis industry

Canopy Growth made a distribution partnership with Southern Glazer Wine & Spirits, a US alcohol distributor. Canopy Growth already has a share of the US CBD market and the new partnership will expand it.

Canopy Growth Expands U.S. CBD Market Reach With Southern Glazer Partnership

These cannabis producers already have a presence south of the border.

4 Canadian Cannabis Companies Poised to Profit from U.S. Legalization

Curaleaf Holdings, Inc.

Green Thumb Industries Inc.

Will it be déjà vu for investors, or is marijuana reform really on its way?

This Upcoming Catalyst Could Send Marijuana Stocks Soaring

Stay away from Canopy Growth stock as it won't be profitable anytime soon. CGC stock won't be moving much higher before the company appears to become profitable.

Canopy Growth Stock Won't Be Profitable Anytime Soon

Canopy Growth recently announced it was acquiring Supreme Cannabis, a promising turnaround story out of Canada. Supreme CEO Beena Goldenberg discusses why CGC was the most compelling suitor, strengthening Canadian position before turning to the US, Acreage and TerrAscend relationships.

Canopy Growth And Canada's Cannabis Consolidation - Interview With Supreme CEO Beena Goldenberg (Video)

Amplify Alternative Harvest ETF

Altria

Constellation Brands

Marijuana stocks have been hot and cold for years. Coming off a strong stretch, investors hope the group -- including these seven marijuana stocks -- can find its footing and go higher.

7 Marijuana Stocks To Buy As Usage Moves Mainstream

Arena Pharmaceuticals

Corbus Pharmaceuticals Holdings

GW Pharmaceuticals

Innovative Industrial Properties

Jazz Pharmaceuticals

Neptune Wellness Solutions Inc.

Turning Point Brands

Village Farms International

22nd Century Group

cbdMD Inc

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week, and look ahead to how the cannabis industry will continue to develop in the 2021.

4/20 Holiday Week Had These Cannabis Stocks Fired Up

Which of These 2 Canadian Pot Stocks Will Gain The Most Value In 2021? The post Canadian Cannabis Stocks To Watch Before Next Week appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Canadian Cannabis Stocks To Watch Before Next Week

Canopy Growth Corp (NASDAQ:CGC) put in a double bottom, co-host Dennis Dick said Thursday on Benzinga's YouTube show "PreMarket Prep." The stock bounced off of critical support at $25 on Wednesday, DIck said, adding that he "would be a buyer of pullbacks" in Canopy Growth.

Canopy Growth Might Be Headed Higher After Its Double Bottom Reversal

Trulieve Cannabis Corp.

The sector has been red-hot this past year, and even mediocre stocks have done well.

Are Canadian Pot Stocks Headed for Another Crash?

Marijuana inhalables and edibles aren't the only things on the market anymore.

Check Out These 2 Innovative Cannabis Stocks That Are Cornering Hot New Markets

News for Canopy Growth Stock (CGC)